Graf Akcie KIN (Kindred Biosciences Inc). Diskuze k akciím KIN. Aktuální informace KIN.

Základní informace o společnosti Kindred Biosciences Inc (Akcie KIN)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 419.31M
Hodnota podniku (EV) N/A
Tržby 7.926M
EBITDA N/A
Zisk -41.95
Růst v tržbách Q/Q -91.06 %
Růst v tržbách Y/Y -81.43 %
P/E (Cena vůči ziskům) 0.00
Forward P/E N/A
EV/Sales 46.63
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 52.90
P/FCF N/A
Price/Book 6.21
Účetní hodnota na akcii 1.49
Hotovost na akcii 1.29
FCF vůči ceně -7.16 %
Počet zaměstnanců 63
Tržba na zaměstnance 125.810k
Profit margin -51.69 %
Operating margin -500.90 %
Gross margin 89.03 %
EBIT margin -514.65 %
EBITDA margin -140.86 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -58.62 %
EPS - Očekávaný růst příští rok -126.67 %
Return on assets -40.03 %
Return on equity -54.55 %
ROIC -20.77 %
ROCE -41.79 %
Dluhy/Equity 0.42
Čistý dluh/EBITDA 2.72
Current ratio 7.02
Quick Ratio 7.02
Volatilita 0.45
Beta 0.00
RSI 69.69
Cílová cena analytiků 12
Známka akcie (dle analytiků) N/A
Insider ownership 4.97 %
Institutional ownership 69.34 %
Počet akcií 45.462M
Procento shortovaných akcií 3.22 %
Short ratio 1.22 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2013
Země United States

Finanční výsledky akcie KIN

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$4.256$1.966------
Cost Of Goods Sold$0.587$0.324------
Gross Profit$3.669$1.642------
Research And Development Expenses$28.31$26.399$17.665$13.861$19.412$18.694$3.14$0.075
SG&A Expenses$37.926$26.499$13.988$8.308$7.85$8.539$1.079$0.045
Other Operating Income Or Expenses--------
Operating Expenses$66.823$53.222$31.653$22.824$27.262$27.233$4.219$0.12
Operating Income$-62.567$-51.256$-31.653$-22.824$-27.262$-27.233$-4.219$-0.12
Total Non-Operating Income/Expense$1.178$1.566$0.774$0.325$0.132$0.094$0.006-
Pre-Tax Income$-61.389$-49.69$-30.879$-22.499$-27.13$-27.139$-4.213$-0.12
Income Taxes--------
Income After Taxes$-61.389$-49.69$-30.879$-22.499$-27.13$-27.139$-4.213$-0.12
Other Income--------
Income From Continuous Operations$-61.389$-49.69$-30.879$-22.499$-27.13$-27.139$-4.213$-0.12
Income From Discontinued Operations--------
Net Income$-61.389$-49.69$-30.879$-22.499$-27.13$-27.139$-4.213$-0.12
EBITDA$-60.457$-50.63$-31.016$-22.395$-26.888$-27.088$-4.216$-0.12
EBIT$-62.567$-51.256$-31.653$-22.824$-27.262$-27.233$-4.219$-0.12
Basic Shares Outstanding39312520201942
Shares Outstanding39312520201942
Basic EPS$-1.59$-1.60$-1.23$-1.13$-1.37$-1.44$-1.13$-0.06
EPS - Earnings Per Share$-1.59$-1.60$-1.23$-1.13$-1.37$-1.44$-1.13$-0.06
# 2020 2019 2018 2017 2016 2015
Current Ratio7.76075.274313.575115.008322.99135.5905
Long-term Debt / Capital0.1904-----
Debt/Equity Ratio0.2352-----
Gross Margin86.207783.5198----
Operating Margin-1470.089-2607.121----
EBIT Margin-1470.089-2607.121----
EBITDA Margin-1420.512-2575.28----
Pre-Tax Profit Margin-1442.411-2527.467----
Net Profit Margin-1442.411-2527.467----
Asset Turnover0.03730.0185----
Inventory Turnover Ratio0.13920.0908----
Receiveable Turnover4.61112.1772----
Days Sales In Receivables79.1577167.6475----
ROE - Return On Equity-74.9368-54.4805-36.4655-39.0066-35.524-27.4065
Return On Tangible Equity-74.9368-54.4805-36.4655-39.0066-35.524-27.4065
ROA - Return On Assets-53.8387-46.6652-33.9995-36.5386-34.0748-26.6278
ROI - Return On Investment-60.6695-54.4805-36.4655-39.0066-35.524-27.4065
Book Value Per Share2.08962.68673.00462.89623.85015.0205
Operating Cash Flow Per Share-0.0048-0.58050.07290.20580.0169-0.7463
Free Cash Flow Per Share0.2183-0.7855-0.11520.19480.0034-0.7657